Carbapenem Susceptibility Rate Against Gram-Positive and Gram-Negative Bacteria and Its Correlation with Consumption

Authors

  • George Arthur Mantiri Medistra Hospital Jakarta, Laboratory and Blood Bank Unit, Jakarta
  • Rheza Paleva Uyanto Medistra Hospital Jakarta, Pharmacy Unit, Jakarta
  • Meita Hendrianingtyas Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang

DOI:

https://doi.org/10.24293/ijcpml.v30i3.2207

Keywords:

Carbapenem, susceptibility, consumption, defined daily dose, non-intensive inpatients

Abstract

Antibiotic susceptibility is significant in patient management and needs close monitoring. This study aims to evaluate the Carbapenem susceptibility profiles and correlation between Carbapenem consumption and susceptibility of the most frequent isolates from blood, sputum, and urine in 2020–2022 from the non-intensive inpatients. The proportion of males and females was 54% and 46%, with the median age group of males and females both being 65-74 years. Higher Meropenem susceptibility was shown in urine isolates of female patients. Lower susceptibility to Meropenem was shown in 2021 compared to 2020 and 2022. Lower susceptibility was shown in isolates from sputum compared to blood and urine. The three-year susceptibility of Carbapenem was decreased compared to 3 years before. The susceptibility of E.coli and S.aureus to Meropenem showed relatively high proportions 95% and 88%, compared to K.pneumoniae (46%), A.baumanii (30%), P.aeruginosa (29%), and others.  The susceptibility of isolates from non-intensive-care inpatients in 2020-2022 showed lower rates compared to the hospital-wide and the previous three years' rates. Meropenem consumption was highest compared to Imipenem with inhibitor and Doripenem. The susceptibility of Gram-negative rods to Meropenem showed higher proportions (58.9%) compared to Gram-positive cocci (26.2%). Carbapenem susceptibility was decreased, along with increased Carbapenem consumption but no significant statistical correlation between the susceptibility rates and the monthly defined daily dose.

Downloads

Download data is not yet available.

References

Ventola CL. The antibiotic resistance crisis: part 1: Causes and threats. P T, 2015; 40(4): 277–83.

Gordon JP, Al Taie A, Miller RL, Dennis JW, Blaskovich MAT, et al. Quantifying the economic and clinical value of reducing antimicrobial resistance in Gram-negative Pathogens causing hospital-acquired infections in Australia. Infect Dis Ther, 2023; 12(7): 1875–89.

Ziolkowski G, Pawlowska I, Krawczyk L, Wojkowska-Mach J. Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014-2015. Journal of Infection and Public Health, 2018; 11(5): 626–30.

Ha DR, Haste NM, Gluckstein DP. The role of antibiotic stewardship in promoting appropriate antibiotic use. Am J Lifestyle Med, 2019; 13(4): 376–83.

Chang CY, Devi Nath N, Lam K, Zaid M. Impact of an Antimicrobial stewardship intervention on the appropriateness of Carbapenem use at a tertiary hospital in Malaysia. Cureus, 2022; 14(11): e31660.

Python 3 [computer software]. Scotts Valley, CA: CreateSpace. Available from: URL: https://www.python.org/ (accessed June 1, 2023).

WHONET 2023 [computer software]. Boston: WHO collaborating centre for surveillance of antimicrobial resistance. Available from: URL: https://whonet.org/ (accessed June 1, 2023).

JASP version 0.17.2 [Computer software]. Amsterdam: University of Amsterdam. 2023. Available from: URL: https:/jasp-stats.org/ (accessed June 1, 2023).

Akhtar N, Singh KS, Prerna, Goyal D, editors. Emerging modalities in mitigation of antimicrobial resistance. 1st Ed., Cham, Springer International Publishing, 2022; 577.

Jean S-S, Harnod D, Hsueh P-R. Global threat of Carbapenem-resistant Gram-negative bacteria. Front Cell Infect Microbiol, 2022; 12(823684): 1–19.

Liang C, Zhang X, Zhou L, Meng G, Zhong L, Peng P. Trends and correlation between antibacterial consumption and carbapenem resistance in Gram-negative bacteria in a tertiary hospital in China from 2012 to 2019. BMC Infect Dis, 2021; 21(1): 444.

Dahesihdewi A, Sugianli AK, Parwati I. Surveilans mikroba dan kepekaannya terhadap antibiotik berdasarkan tipe rumah sakit di Indonesia tahun 2018. Jakarta: Perhimpunan Dokter Spesialis Patologi Klinik dan Kedokteran Laboratorium Indonesia. 2019. Available from: URL: https://www.pdspatklin.or.id/assets/files/pdspatklin_2021_12_05_06_54_04.pdf (accessed June 1, 2023).

Wang R, Yang Q, Zhang S, Hong Y, Zhang M, Jiang S. Trends and correlation of antibiotic susceptibility and antibiotic consumption at a large teaching hospital in China (2007-2016): A surveillance study. Ther Clin Risk Manag, 2019; 15: 1019–27.

Zurfluh K, Hindermann D, Nüesch-Inderbinen M, Poirel L, Nordmann P, Stephan R. Occurrence and features of chromosomally encoded carbapenemases in Gram-negative bacteria in farm animals sampled at slaughterhouse level. Schweiz Arch Tierheilkd, 2016; 158(6): 457–60.

Capelo-Martínez J-L, Igrejas G, editors. Antibiotic drug resistance. 1st Ed., Hoboken, New Jersey, John Wiley & Sons, 2020; 267.

Mollenkopf DF, Stull JW, Mathys DA, Bowman AS, Feicht SM, et al. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agents Chemother, 2017; 61(2): e01298-16.

Downloads

Submitted

2023-07-04

Accepted

2024-01-30

Published

2024-06-06

How to Cite

[1]
Mantiri, G.A., Uyanto, R.P. and Hendrianingtyas, M. 2024. Carbapenem Susceptibility Rate Against Gram-Positive and Gram-Negative Bacteria and Its Correlation with Consumption . INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 3 (Jun. 2024), 228–232. DOI:https://doi.org/10.24293/ijcpml.v30i3.2207.

Issue

Section

Articles